查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2092203

藥用明膠市場：全球市場預測（2026-2032）

Pharmaceutical Gelatin Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，藥用明膠市場將成長至 19.8 億美元，複合年成長率為 6.18%。

主要市場統計數據
基準年（2025 年） 13億美元
預計年份（2026年） 13.8億美元
預測年份（2032年） 19.8億美元
複合年成長率（） 6.18%

藥用明膠是一種高純度、生物相容性良好的輔料，廣泛應用於硬膠囊和軟膠囊包衣、藥片包衣、微膠囊化、止血、血漿膨鬆劑、創傷護理基質和疫苗穩定等領域。其功能價值源自於其可控的凝膠強度、黏度、成膜性、熱可逆性、易消化性以及與活性成分的相容性。隨著口服固體製劑、營養補充劑膠囊、生物製藥製劑以及需要可靠膠囊殼和控釋性能的便捷給藥技術的不斷擴展，市場對口服固體製劑的需求也日益成長。

此外，藥用級明膠的市場趨勢也受到更嚴格的藥典標準、可追溯性要求、過敏原和傳染性腦病變(TSE) 控制以及對牛、豬和魚類原料日益嚴格的審查的影響。製造商和藥品採購商優先考慮符合良好生產規範 (GMP)、內毒素控制、重金屬監測、微生物安全、清真和猶太潔食認證（如適用）以及整個供應鏈中完善的文件記錄。隨著藥品研發人員追求更快的配方週期和更廣泛的法規核准，藥用級明膠仍然是商業性成功的關鍵因素，而穩定的品質、監管透明度和可靠的供應是其中的關鍵要素。

藥用明膠產業的劇變

藥用明膠產業正經歷結構性轉變，從採購通用輔料轉向以品質為導向、針對特定應用的採購。膠囊生產商、合約開發合作夥伴和藥物製劑開發人員越來越需要針對不同性能的明膠，例如凝固強度、黏度、顏色、透明度、溶出性能、抗交聯性以及與吸濕性或氧敏感成分的相容性。這加速了更嚴格的規格控制、更高的供應商合格以及製劑開發支援服務的普及。

人工智慧對製藥明膠領域的累積影響

人工智慧 (AI) 在藥用明膠的生產、品質保證、採購和配方開發等各個領域都發揮著日益重要的作用。在生產環節，AI 驅動的製程分析能夠更精確地控制萃取、過濾、蒸發、滅菌、乾燥和研磨等參數，從而幫助生產商提高批次間在凝膠強度、黏度、粒徑、水分含量、灰分含量和微生物限度等方面的一致性。此外，預測性維護和異常檢測有助於在受監管的生產環境中保持運轉率，並降低品質波動。

區域藥用明膠的關鍵見解

亞太地區是藥用明膠的主要成長市場，這得益於中國、印度、日本、韓國、澳洲和東南亞國協的大規模膠囊生產、不斷擴大的學名藥生產、膳食補充劑的強勁消費以及對醫藥基礎設施投資的增加。該地區擁有成熟的明膠加工能力，對硬膠囊和軟膠囊的需求量巨大，但監管協調和出口導向生產模式的推進，使得確保符合藥典要求和原料可追溯性變得愈發重要。

對與藥用明膠相關的主要群體進行分析

由於藥品包裝和營養補充品生產的擴張，以及該地區對經濟實惠的口服劑型需求的成長，東協市場對藥用明膠的重要性日益凸顯。該地區多元化的法規環境要求供應商確保文件齊全，符合穆斯林占多數市場的清真標準，並為本地和出口型生產商提供穩定的品質。在海灣合作理事會（GCC）國家，遵守清真標準、醫療保健系統現代化以及藥品進口品管備受重視，因此，經認證的牛和魚源明膠對於膠囊和醫療應用至關重要。

對各國藥用級明膠進行分析。

美國是全球最先進的藥用明膠市場之一，這得益於對處方箋膠囊、非處方藥、膳食補充劑軟膠囊的強勁需求，以及嚴格的輔料品質管理系統。加拿大也面臨類似的品質標準，其需求與藥品、膳食補充劑和保健品的合規性密切相關。墨西哥受益於不斷擴大的藥品生產、接近性北美供應鏈以及對價格適中的口服劑型日益成長的需求。巴西是拉丁美洲領先的市場，這得益於其國內藥品生產、不斷成長的膳食補充劑市場以及醫療保健覆蓋範圍的擴大。

為製藥明膠產業的領導者提供的實用建議

產業領導者應優先考慮「品質第一」的明膠籌資策略，使膠囊、片劑、軟膠囊、止血劑和緩釋製劑的最終合格和技術規格保持一致。供應商資質應包括原料可追溯性、GMP合規性、藥典合規性、微生物和內毒素控制、傳染性腦病變（TSE）文件、適用的清真或猶太潔食認證，以及檢驗的變更管理流程。

藥用級明膠的分析方法

本報告採用綜合研究方法，結合二手資料、法規審查和一手檢驗，確保了藥用明膠研究的準確性和產業相關性。二手資料包括藥典標準、藥用輔料和動物源性成分的法規指南、公共衛生機構文件、行業期刊、科學文獻、專利趨勢、劑型開發趨勢以及已記錄的生產規範。報告重點在於明膠的各項規格，例如凝固強度、黏度、微生物限量、內毒素控制、水分含量、灰分、重金屬含量以及原料合規性要求。

結論

藥用明膠憑藉其多功能性、可靠的安全性以及在膠囊、軟膠囊、片劑、止血劑和特種製劑中的出色功能，在現代藥物遞送領域繼續發揮著至關重要的作用。隨著買家對可追溯性、品管、特定應用功能以及符合全球監管機構審查要求的文件資料提出更高的要求，該行業正變得日益複雜。

目錄

第1章 引言

第2章 分析方法

  • 分析設計
  • 分析框架
  • 市場規模預測
  • 數據三角測量
  • 分析結果
  • 分析的前提條件
  • 分析的局限性

第3章執行摘要

  • 首席體驗長的觀點
  • 市場規模和成長趨勢
  • 市佔率分析（2025 年）
  • FPNV定位矩陣（2025）
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入（GTM）策略

第5章 市場洞察

  • 消費者分析與最終用戶觀點
  • 消費者體驗基準測試
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 成本效益分析（ROI）和成本效益分析（CBA）

第6章：人工智慧（AI）的累積影響（2026 年）

第7章 藥用明膠市場：依類型分類

  • A型
  • B型

第8章：藥用明膠市場：依形態分類

  • 粉末
  • 座位
  • 顆粒

第9章 藥用明膠市場：依原料分類

  • 豬
  • 牛皮
  • 牛
  • 魚貝類
  • 家禽

第10章：藥用明膠市場：依應用領域分類

  • 硬膠囊
  • 可吸收止血材料
  • 軟膠囊
  • 藥片包衣
  • 傷口敷料

第11章 藥用明膠市場：依分銷管道分類

  • 離線
  • 線上

第12章 藥用明膠市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章 藥用明膠市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 藥用明膠市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 市佔率分析（2025 年）
  • FPNV定位矩陣（2025）
  • 市場集中度分析（2025 年）
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析（2025 年）
  • 產品系列分析（2025 年）
  • 基準分析（2025 年）

第16章：公司簡介

  • Baotou Dongbao Bio-Tech Co., Ltd.
  • Darling Ingredients Inc.
  • Ewald-Gelatine GmbH
  • Gelita AG
  • Gelken Gelatin Co., Ltd.
  • Gelnex Industria e Comercio Ltda.
  • Geltech Co., Ltd.
  • Henan Boom Gelatin Co., Ltd.
  • India Gelatine & Chemicals Ltd.
  • ITALGEL Srl
  • Jiangxi Gelatins Co., Ltd.
  • Junca Gelatines SL
  • Lapi Gelatine Spa
  • Nippi Inc.
  • Nitta Gelatin Inc.
  • Norland Products Inc.
  • PB Leiner
  • Qinghai Gelatin Co., Ltd.
  • Rousselot SAS
  • Sterling Biotech Ltd.
  • Suheung Co., Ltd
  • Tessenderlo Group NV
  • Trobas Gelatine BV
  • Weishardt Group
  • Xiamen Gelken Gelatin Co., Ltd.
Product Code: MRR-4F4C36263656

The Pharmaceutical Gelatin Market is projected to grow by USD 1.98 billion at a CAGR of 6.18% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.30 billion
Estimated Year [2026] USD 1.38 billion
Forecast Year [2032] USD 1.98 billion
CAGR (%) 6.18%

Pharmaceutical gelatin is a highly purified, biocompatible excipient used across hard and soft capsules, tablet coating, microencapsulation, hemostatic applications, plasma expanders, wound care matrices, and vaccine stabilization. Its functional value stems from controlled gel strength, viscosity, film-forming capability, thermal reversibility, digestibility, and compatibility with active pharmaceutical ingredients. Demand is shaped by the continued expansion of oral solid dosage forms, nutraceutical capsules, biologics delivery formats, and patient-friendly dosage technologies that require reliable capsule shells and controlled release performance.

The pharmaceutical gelatin landscape is also being influenced by stricter pharmacopeial standards, traceability requirements, allergen and transmissible spongiform encephalopathy controls, and heightened scrutiny of bovine, porcine, and fish-derived raw materials. Manufacturers and pharmaceutical buyers are prioritizing Good Manufacturing Practice compliance, endotoxin control, heavy metal monitoring, microbial safety, halal and kosher certification where applicable, and robust documentation across the supply chain. As drug developers pursue faster formulation cycles and broader geographic registration, pharmaceutical-grade gelatin remains a critical material where quality consistency, regulatory transparency, and supply resilience determine commercial success.

Transformative Shifts in the Pharmaceutical Gelatin Landscape

The pharmaceutical gelatin industry is undergoing a structural shift from commodity excipient procurement toward quality-led, application-specific sourcing. Capsule manufacturers, contract development partners, and pharmaceutical formulators increasingly require gelatin grades tailored to bloom strength, viscosity, color, clarity, dissolution behavior, cross-linking resistance, and compatibility with hygroscopic or oxygen-sensitive ingredients. This is accelerating the use of tighter specification management, enhanced supplier qualification, and formulation support services.

Another transformative shift is the growing focus on raw material provenance and sustainability. Regulatory expectations and end-user preferences are pushing the industry toward full traceability from hide, bone, or fish source to finished excipient. In parallel, gelatin suppliers are strengthening segregation systems for religious, dietary, and regional compliance needs, including bovine, porcine-free, halal, kosher, and fish gelatin options. The industry is also responding to capsule innovation, including enteric-release softgels, moisture-sensitive formulations, and clean-label nutraceutical-pharma convergence. These developments are positioning pharmaceutical gelatin as a strategic excipient rather than a standard input material.

Cumulative Impact of Artificial Intelligence on Pharmaceutical Gelatin

Artificial intelligence is increasingly relevant across pharmaceutical gelatin production, quality assurance, procurement, and formulation development. In manufacturing, AI-enabled process analytics can support tighter control of extraction, filtration, evaporation, sterilization, drying, and milling parameters, helping producers improve batch consistency for bloom strength, viscosity, particle size, moisture, ash, and microbial limits. Predictive maintenance and anomaly detection also support uptime and reduce quality deviations in regulated production environments.

In quality and regulatory functions, machine learning tools can accelerate document review, certificate-of-analysis comparison, deviation trending, supplier risk scoring, and pharmacopoeial compliance monitoring. For formulation scientists, AI can assist in predicting capsule shell behavior, dissolution performance, gelatin cross-linking risk, plasticizer interactions, and stability outcomes under varying humidity and temperature conditions. In supply chain operations, AI-supported demand sensing and risk mapping can improve visibility into animal-origin raw material availability, logistics disruptions, and regulatory restrictions. The cumulative impact is a move toward more data-rich, transparent, and responsive pharmaceutical gelatin operations while maintaining human oversight for GMP decisions, validation, and regulatory accountability.

Key Regional Insights for Pharmaceutical Gelatin

Asia-Pacific is a major growth environment for pharmaceutical gelatin, supported by large-scale capsule manufacturing, expanding generic drug production, strong nutraceutical consumption, and rising investments in pharmaceutical infrastructure across China, India, Japan, South Korea, Australia, and ASEAN economies. The region benefits from established gelatin processing capabilities and high-volume demand for hard capsules and softgels, while regulatory harmonization efforts and export-oriented manufacturing increase the importance of pharmacopeial compliance and traceable raw material sourcing.

North America demonstrates mature demand driven by advanced pharmaceutical manufacturing, dietary supplement innovation, biologics research, and stringent U.S. and Canadian regulatory expectations for excipient quality, animal-origin documentation, and supplier qualification. Latin America is shaped by growing healthcare access, expanding generic medicine consumption, and increasing local production of capsules and nutraceutical dosage forms, with Brazil and Mexico acting as important regional anchors. Europe remains highly quality-driven, with strong emphasis on European Pharmacopoeia compliance, transmissible spongiform encephalopathy risk controls, sustainability documentation, and preference for fully traceable supply chains. The Middle East is influenced by halal-certified pharmaceutical and nutraceutical products, increasing healthcare investment, and import-dependent supply structures, while Africa is gradually expanding its pharmaceutical manufacturing capacity, supported by public health initiatives, essential medicine demand, and regional efforts to improve medicine availability and quality assurance.

Key Group Insights for Pharmaceutical Gelatin

ASEAN markets are increasingly relevant for pharmaceutical gelatin because of expanding pharmaceutical packaging, nutraceutical production, and regional demand for cost-effective oral dosage forms. The group's diverse regulatory environments require suppliers to manage documentation, halal alignment in majority-Muslim markets, and quality consistency for regional and export-oriented manufacturers. GCC countries place a strong emphasis on halal compliance, healthcare system modernization, and pharmaceutical import quality controls, making certified bovine and fish gelatin options important for capsule and medical applications.

The European Union shapes global pharmaceutical gelatin standards through strict excipient regulation, pharmacopoeial alignment, sustainability expectations, and documentation requirements for animal-derived materials. BRICS economies collectively influence demand through large populations, expanding domestic pharmaceutical manufacturing, and policy efforts to improve medicine self-sufficiency, with China, India, Brazil, and South Africa contributing to regionalized supply chain development. G7 countries represent highly regulated, innovation-led consumption environments where gelatin is used in advanced formulations, premium softgels, and medical applications under rigorous quality systems. NATO member economies, particularly those in North America and Europe, add an additional layer of strategic supply chain focus, as pharmaceutical resilience, domestic manufacturing capacity, and secure access to critical excipients become priorities in healthcare preparedness planning.

Key Country Insights for Pharmaceutical Gelatin

The United States is one of the most advanced pharmaceutical gelatin markets, supported by strong demand for prescription capsules, over-the-counter drugs, nutraceutical softgels, and regulated excipient quality systems. Canada follows similar quality expectations, with demand tied to pharmaceuticals, dietary supplements, and health product compliance. Mexico benefits from growing pharmaceutical manufacturing, proximity to North American supply chains, and rising consumption of affordable oral dosage forms. Brazil is a leading Latin American market, supported by domestic medicine production, nutraceutical growth, and expanding healthcare access.

In Europe, the United Kingdom remains important for pharmaceutical innovation, contract development, and high-specification excipient demand. Germany's strength in pharmaceutical manufacturing, medical technology, and quality assurance reinforces demand for tightly controlled gelatin grades. France supports demand through its pharmaceutical, nutraceutical, and cosmetic-health sectors, while Russia's localization policies and domestic drug production initiatives influence gelatin sourcing needs. Italy and Spain contribute through established pharmaceutical production, softgel manufacturing, and nutraceutical consumption.

In Asia-Pacific, China combines large-scale capsule manufacturing, pharmaceutical production, and domestic gelatin processing capabilities, making quality control and export compliance central considerations. India is a major user of pharmaceutical gelatin due to its extensive generic drug and capsule manufacturing base, with rising emphasis on global regulatory compliance. Japan prioritizes high-purity excipients, quality consistency, and advanced dosage technologies, while Australia's demand is supported by complementary medicines, regulated health products, and import quality controls. South Korea is driven by innovative pharmaceuticals, nutraceutical softgels, and advanced manufacturing standards, strengthening demand for reliable pharmaceutical-grade gelatin.

Actionable Recommendations for Pharmaceutical Gelatin Industry Leaders

Industry leaders should prioritize a quality-first gelatin sourcing strategy that aligns technical specifications with end-use performance in capsules, tablets, softgels, hemostats, and controlled-release systems. Supplier qualification should include raw material traceability, GMP alignment, pharmacopeial compliance, microbial and endotoxin controls, transmissible spongiform encephalopathy documentation, halal or kosher certification where relevant, and validated change-control processes.

Manufacturers should invest in digital quality management, AI-enabled process monitoring, and predictive supply chain risk assessment to reduce deviations and improve batch-to-batch consistency. Formulation teams should collaborate earlier with gelatin suppliers to address dissolution, cross-linking, moisture sensitivity, plasticizer compatibility, and stability risks. Procurement leaders should diversify approved sources across bovine, porcine, and fish gelatin where formulation and regulatory requirements allow, while maintaining robust equivalency testing. Companies serving multiple regions should build documentation packages that support U.S., European, Japanese, and emerging-market registration expectations to reduce approval delays and strengthen customer confidence.

Research Methodology for Pharmaceutical Gelatin Insights

The research approach for pharmaceutical gelatin combines secondary research, regulatory review, and primary validation to ensure accuracy and industry relevance. Secondary inputs include pharmacopeial standards, regulatory guidance on pharmaceutical excipients and animal-origin materials, public health agency documents, trade publications, scientific literature, patent activity, dosage form development trends, and documented manufacturing practices. Particular attention is given to gelatin specifications such as bloom strength, viscosity, microbial limits, endotoxin control, moisture, ash, heavy metals, and source-based compliance requirements.

Primary validation typically involves structured discussions with excipient specialists, capsule manufacturers, pharmaceutical formulators, quality assurance professionals, procurement leaders, regulatory affairs experts, and distribution stakeholders. Findings are triangulated across multiple verified sources to identify consistent demand drivers, technology shifts, regulatory priorities, and regional differences. The methodology excludes speculative sizing and forecasting and focuses instead on evidence-backed qualitative insights, supply chain behavior, technical requirements, and strategic implications for pharmaceutical gelatin stakeholders.

Conclusion

Pharmaceutical gelatin continues to play an essential role in modern drug delivery, supported by its versatility, proven safety profile, and functional performance across capsules, softgels, tablets, hemostatic products, and specialized formulations. The industry is becoming more sophisticated as buyers demand greater traceability, tighter quality controls, application-specific functionality, and documentation suitable for global regulatory review.

The next phase of competitive advantage will depend on resilient sourcing, digitalized quality systems, AI-supported process intelligence, and closer collaboration between gelatin suppliers and pharmaceutical developers. Regions and countries with strong regulatory frameworks, manufacturing capacity, and excipient expertise will continue shaping best practices, while emerging markets expand access to gelatin-based dosage forms. For industry participants, success will come from treating pharmaceutical gelatin as a strategic excipient that connects formulation performance, patient acceptability, regulatory compliance, and supply chain reliability.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Pharmaceutical Gelatin Market, by Type

  • 7.1. Introduction
  • 7.2. Type A
  • 7.3. Type B

8. Pharmaceutical Gelatin Market, by Form

  • 8.1. Introduction
  • 8.2. Powder
  • 8.3. Sheet
  • 8.4. Granules

9. Pharmaceutical Gelatin Market, by Source

  • 9.1. Introduction
  • 9.2. Porcine
  • 9.3. Bovine Skin
  • 9.4. Bovine Bone
  • 9.5. Marine
  • 9.6. Poultry

10. Pharmaceutical Gelatin Market, by Application

  • 10.1. Introduction
  • 10.2. Hard Capsule
  • 10.3. Absorbable Hemostats
  • 10.4. Soft Capsule
  • 10.5. Tablet Coating
  • 10.6. Wound Dressings

11. Pharmaceutical Gelatin Market, by Distribution Channel

  • 11.1. Introduction
  • 11.2. Offline
  • 11.3. Online

12. Pharmaceutical Gelatin Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Pharmaceutical Gelatin Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Pharmaceutical Gelatin Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2025
  • 15.2. FPNV Positioning Matrix, 2025
  • 15.3. Market Concentration Analysis, 2025
    • 15.3.1. Concentration Ratio (CR)
    • 15.3.2. Herfindahl Hirschman Index (HHI)
  • 15.4. Recent Developments & Impact Analysis, 2025
  • 15.5. Product Portfolio Analysis, 2025
  • 15.6. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Baotou Dongbao Bio-Tech Co., Ltd.
  • 16.2. Darling Ingredients Inc.
  • 16.3. Ewald-Gelatine GmbH
  • 16.4. Gelita AG
  • 16.5. Gelken Gelatin Co., Ltd.
  • 16.6. Gelnex Industria e Comercio Ltda.
  • 16.7. Geltech Co., Ltd.
  • 16.8. Henan Boom Gelatin Co., Ltd.
  • 16.9. India Gelatine & Chemicals Ltd.
  • 16.10. ITALGEL S.r.l.
  • 16.11. Jiangxi Gelatins Co., Ltd.
  • 16.12. Junca Gelatines S.L.
  • 16.13. Lapi Gelatine S.p.a.
  • 16.14. Nippi Inc.
  • 16.15. Nitta Gelatin Inc.
  • 16.16. Norland Products Inc.
  • 16.17. PB Leiner
  • 16.18. Qinghai Gelatin Co., Ltd.
  • 16.19. Rousselot S.A.S.
  • 16.20. Sterling Biotech Ltd.
  • 16.21. Suheung Co., Ltd
  • 16.22. Tessenderlo Group NV
  • 16.23. Trobas Gelatine BV
  • 16.24. Weishardt Group
  • 16.25. Xiamen Gelken Gelatin Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL PHARMACEUTICAL GELATIN MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL PHARMACEUTICAL GELATIN MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL PHARMACEUTICAL GELATIN MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL PHARMACEUTICAL GELATIN MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2025 VS 2032 (%)
  • FIGURE 7. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL PHARMACEUTICAL GELATIN MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 23. GLOBAL PHARMACEUTICAL GELATIN MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

  • TABLE 1. GLOBAL PHARMACEUTICAL GELATIN MARKET SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL TYPE A MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL TYPE A MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL TYPE A MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL TYPE B MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL TYPE B MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL TYPE B MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL POWDER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL POWDER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL POWDER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SHEET MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SHEET MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SHEET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL GRANULES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL GRANULES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL GRANULES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PORCINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PORCINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PORCINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BOVINE SKIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BOVINE SKIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BOVINE SKIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BOVINE BONE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BOVINE BONE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BOVINE BONE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MARINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MARINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MARINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL POULTRY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL POULTRY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL POULTRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL HARD CAPSULE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL HARD CAPSULE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL HARD CAPSULE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ABSORBABLE HEMOSTATS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ABSORBABLE HEMOSTATS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ABSORBABLE HEMOSTATS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SOFT CAPSULE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL SOFT CAPSULE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SOFT CAPSULE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL TABLET COATING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL TABLET COATING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL TABLET COATING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL WOUND DRESSINGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL WOUND DRESSINGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL WOUND DRESSINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ONLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC PHARMACEUTICAL GELATIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 66. NORTH AMERICA PHARMACEUTICAL GELATIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 68. NORTH AMERICA PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 69. NORTH AMERICA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 72. LATIN AMERICA PHARMACEUTICAL GELATIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. LATIN AMERICA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 74. LATIN AMERICA PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 75. LATIN AMERICA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 76. LATIN AMERICA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE PHARMACEUTICAL GELATIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 84. MIDDLE EAST PHARMACEUTICAL GELATIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. MIDDLE EAST PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 86. MIDDLE EAST PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 87. MIDDLE EAST PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 88. MIDDLE EAST PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 89. MIDDLE EAST PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 90. AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 93. AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 94. AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 95. AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. ASEAN PHARMACEUTICAL GELATIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. ASEAN PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. ASEAN PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 100. ASEAN PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 101. ASEAN PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 102. ASEAN PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 103. GCC PHARMACEUTICAL GELATIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GCC PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. GCC PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 106. GCC PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 107. GCC PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 108. GCC PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPEAN UNION PHARMACEUTICAL GELATIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPEAN UNION PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPEAN UNION PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPEAN UNION PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPEAN UNION PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPEAN UNION PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 115. BRICS PHARMACEUTICAL GELATIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. BRICS PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. BRICS PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 118. BRICS PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 119. BRICS PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 120. BRICS PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 121. G7 PHARMACEUTICAL GELATIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. G7 PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. G7 PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 124. G7 PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 125. G7 PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. G7 PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 127. NATO PHARMACEUTICAL GELATIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. NATO PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. NATO PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 130. NATO PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 131. NATO PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 132. NATO PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. UNITED STATES PHARMACEUTICAL GELATIN MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 135. UNITED STATES PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. UNITED STATES PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 137. UNITED STATES PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 138. UNITED STATES PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. UNITED STATES PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 140. CANADA PHARMACEUTICAL GELATIN MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 141. CANADA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. CANADA PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 143. CANADA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 144. CANADA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 145. CANADA PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 146. MEXICO PHARMACEUTICAL GELATIN MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 147. MEXICO PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. MEXICO PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 149. MEXICO PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 150. MEXICO PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. MEXICO PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 152. BRAZIL PHARMACEUTICAL GELATIN MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 153. BRAZIL PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. BRAZIL PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 155. BRAZIL PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 156. BRAZIL PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. BRAZIL PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 158. UNITED KINGDOM PHARMACEUTICAL GELATIN MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 159. UNITED KINGDOM PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. UNITED KINGDOM PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 161. UNITED KINGDOM PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 162. UNITED KINGDOM PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. UNITED KINGDOM PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 164. GERMANY PHARMACEUTICAL GELATIN MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 165. GERMANY PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. GERMANY PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 167. GERMANY PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 168. GERMANY PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 169. GERMANY PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 170. FRANCE PHARMACEUTICAL GELATIN MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 171. FRANCE PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. FRANCE PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 173. FRANCE PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 174. FRANCE PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 175. FRANCE PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 176. RUSSIA PHARMACEUTICAL GELATIN MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 177. RUSSIA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. RUSSIA PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 179. RUSSIA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 180. RUSSIA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 181. RUSSIA PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 182. ITALY PHARMACEUTICAL GELATIN MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 183. ITALY PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. ITALY PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 185. ITALY PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 186. ITALY PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 187. ITALY PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 188. SPAIN PHARMACEUTICAL GELATIN MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 189. SPAIN PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. SPAIN PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 191. SPAIN PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 192. SPAIN PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 193. SPAIN PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 194. CHINA PHARMACEUTICAL GELATIN MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 195. CHINA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. CHINA PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 197. CHINA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 198. CHINA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 199. CHINA PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 200. INDIA PHARMACEUTICAL GELATIN MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 201. INDIA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. INDIA PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 203. INDIA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 204. INDIA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 205. INDIA PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 206. JAPAN PHARMACEUTICAL GELATIN MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 207. JAPAN PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 208. JAPAN PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 209. JAPAN PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 210. JAPAN PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 211. JAPAN PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 212. AUSTRALIA PHARMACEUTICAL GELATIN MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 213. AUSTRALIA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. AUSTRALIA PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 215. AUSTRALIA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 216. AUSTRALIA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 217. AUSTRALIA PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 218. SOUTH KOREA PHARMACEUTICAL GELATIN MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 219. SOUTH KOREA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. SOUTH KOREA PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 221. SOUTH KOREA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 222. SOUTH KOREA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 223. SOUTH KOREA PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 224. GLOBAL PHARMACEUTICAL GELATIN MARKET SHARE, BY KEY PLAYER, 2025
  • TABLE 225. GLOBAL PHARMACEUTICAL GELATIN MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025